Logo image of IMKTA

INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

NASDAQ:IMKTA - Nasdaq - US4570301048 - Common Stock - Currency: USD

62.44  -1.11 (-1.75%)

After market: 62.44 0 (0%)

Fundamental Rating

4

IMKTA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 40 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and the financial health of IMKTA get a neutral evaluation. Nothing too spectacular is happening here. IMKTA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year IMKTA was profitable.
IMKTA had a positive operating cash flow in the past year.
In the past 5 years IMKTA has always been profitable.
In the past 5 years IMKTA always reported a positive cash flow from operatings.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of IMKTA (3.16%) is comparable to the rest of the industry.
The Return On Equity of IMKTA (5.04%) is comparable to the rest of the industry.
IMKTA's Return On Invested Capital of 4.58% is on the low side compared to the rest of the industry. IMKTA is outperformed by 62.50% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMKTA is above the industry average of 7.93%.
The last Return On Invested Capital (4.58%) for IMKTA is well below the 3 year average (10.21%), which needs to be investigated, but indicates that IMKTA had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.16%
ROE 5.04%
ROIC 4.58%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

IMKTA's Profit Margin of 1.45% is in line compared to the rest of the industry. IMKTA outperforms 57.50% of its industry peers.
IMKTA's Profit Margin has been stable in the last couple of years.
IMKTA's Operating Margin of 2.47% is in line compared to the rest of the industry. IMKTA outperforms 52.50% of its industry peers.
In the last couple of years the Operating Margin of IMKTA has declined.
IMKTA has a Gross Margin (23.55%) which is comparable to the rest of the industry.
IMKTA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.47%
PM (TTM) 1.45%
GM 23.55%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IMKTA is creating some value.
The number of shares outstanding for IMKTA remains at a similar level compared to 1 year ago.
IMKTA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IMKTA has been reduced compared to a year ago.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 4.31 indicates that IMKTA is not in any danger for bankruptcy at the moment.
IMKTA's Altman-Z score of 4.31 is in line compared to the rest of the industry. IMKTA outperforms 55.00% of its industry peers.
The Debt to FCF ratio of IMKTA is 29.74, which is on the high side as it means it would take IMKTA, 29.74 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IMKTA (29.74) is worse than 70.00% of its industry peers.
IMKTA has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
IMKTA has a Debt to Equity ratio of 0.33. This is comparable to the rest of the industry: IMKTA outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 29.74
Altman-Z 4.31
ROIC/WACC0.64
WACC7.13%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 3.24 indicates that IMKTA has no problem at all paying its short term obligations.
IMKTA has a better Current ratio (3.24) than 92.50% of its industry peers.
IMKTA has a Quick Ratio of 1.45. This is a normal value and indicates that IMKTA is financially healthy and should not expect problems in meeting its short term obligations.
IMKTA has a Quick ratio of 1.45. This is amongst the best in the industry. IMKTA outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 1.45
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

IMKTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.41%.
The Earnings Per Share has been growing slightly by 6.65% on average over the past years.
IMKTA shows a decrease in Revenue. In the last year, the revenue decreased by -7.38%.
Measured over the past years, IMKTA shows a small growth in Revenue. The Revenue has been growing by 6.06% on average per year.
EPS 1Y (TTM)-57.41%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-61.84%
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-13.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2022 5 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

IMKTA is valuated correctly with a Price/Earnings ratio of 15.08.
Based on the Price/Earnings ratio, IMKTA is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.10, IMKTA is valued a bit cheaper.
Industry RankSector Rank
PE 15.08
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMKTA is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMKTA indicates a slightly more expensive valuation: IMKTA is more expensive than 67.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 66.25
EV/EBITDA 5.69
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.27
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

IMKTA has a Yearly Dividend Yield of 1.07%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.30, IMKTA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.43, IMKTA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.07%

5.2 History

The dividend of IMKTA has a limited annual growth rate of 0.12%.
IMKTA has been paying a dividend for at least 10 years, so it has a reliable track record.
IMKTA has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

15.58% of the earnings are spent on dividend by IMKTA. This is a low number and sustainable payout ratio.
IMKTA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP15.58%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

More info and screens

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (5/6/2025, 4:30:02 PM)

After market: 62.44 0 (0%)

62.44

-1.11 (-1.75%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-08 2025-05-08
Inst Owners90.19%
Inst Owner Change-0.47%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.19B
Analysts84.44
Price TargetN/A
Short Float %5.14%
Short Ratio5.71
Dividend
Industry RankSector Rank
Dividend Yield 1.07%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP15.58%
Div Incr Years0
Div Non Decr Years11
Ex-Date04-10 2025-04-10 (0.165)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.08
Fwd PE N/A
P/S 0.22
P/FCF 66.25
P/OCF 5.83
P/B 0.76
P/tB 0.76
EV/EBITDA 5.69
EPS(TTM)4.14
EY6.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.94
FCFY1.51%
OCF(TTM)10.71
OCFY17.15%
SpS286.82
BVpS82.23
TBVpS82.23
PEG (NY)N/A
PEG (5Y)2.27
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 5.04%
ROCE 6.06%
ROIC 4.58%
ROICexc 5.22%
ROICexgc 5.22%
OM 2.47%
PM (TTM) 1.45%
GM 23.55%
FCFM 0.33%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
ROICexc(3y)11.97%
ROICexc(5y)12.99%
ROICexgc(3y)11.97%
ROICexgc(5y)12.99%
ROCE(3y)13.5%
ROCE(5y)15.58%
ROICexcg growth 3Y-23.42%
ROICexcg growth 5Y-0.13%
ROICexc growth 3Y-23.42%
ROICexc growth 5Y-0.13%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
F-Score6
Asset Turnover2.18
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 29.74
Debt/EBITDA 1.99
Cap/Depr 149.8%
Cap/Sales 3.4%
Interest Coverage 250
Cash Conversion 78.76%
Profit Quality 22.73%
Current Ratio 3.24
Quick Ratio 1.45
Altman-Z 4.31
F-Score6
WACC7.13%
ROIC/WACC0.64
Cap/Depr(3y)141.53%
Cap/Depr(5y)130.04%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.85%
Profit Quality(3y)57.87%
Profit Quality(5y)73.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-57.41%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-61.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-13.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.99%
EBIT growth 3Y-20.18%
EBIT growth 5Y3.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-87.59%
FCF growth 3Y-32.19%
FCF growth 5Y0.76%
OCF growth 1Y-32.62%
OCF growth 3Y-5.01%
OCF growth 5Y4.42%